Where will Rosetta go now?

No Nogo Now Where to Go?

Nogo-A, a reticulon protein expressed by oligodendrocytes, contributes to the axonal growth inhibitory action of central myelin in growth cone collapse and neurite outgrowth in vitro assays, and antibody and inhibitor studies have implicated a role for Nogo in regeneration in the adult CNS in vivo. Three independent labs have now produced Nogo knockout mice with, quite unexpectedly, three diffe...

Summarising: Where Are We Now? Where Should We Go?

Why Rat’s Will Go Where Rats Will Not

Compound words with irregular plural nouns in first position (e.g. mice-eater) are produced far more frequently than compound words with regular plural nouns in first position (e.g. *rats-eater), (Gordon, 1985). Using empirical evidence and neural net modelling, the studies presented here demonstrate how a single route, associative memory based account might provide an equally, if not more, val...

Why will rat's go where rats will not?

Experimental evidence indicates that regular plurals are nearly always omitted from English compounds (e.g., rats-eater) while irregular plurals may be included within these structures (e.g., mice-chaser). This phenomenon is considered to be good evidence to support the dual mechanism model of morphological processing (Pinker & Prince, 1992). However, evidence from neural net modelling has show...

Immune activation and coronary atherosclerosis in HIV-infected women: where are we now, and where will we go next?

Understanding the pathophysiology of coronary heart disease (CHD) in the human immunodeficiency virus (HIV)– infected population with access to antiretroviral therapy (ART) has become an important focus of recent research. CHD is, in fact, an emerging complication for individuals infected with HIV and presents a challenge for physicians involved in the care of HIV-infected patients. Cardiovascu...